iLabService
+163%
est. 2Y upside i
AI powered Lab Operation Management SaaS Platform
Rank
#123
Sector
Lab Operations Management Software
Est. Liquidity
~2Y
Data Quality
Data: MediumiLabService presents a high-risk, high-reward equity opportunity with an expected 2-year upside of 163% net of dilution.
Last updated: July 19, 2026
Revenue reaches $4.78M and exit multiple expands to 8x (in line with peer Veeva's forward multiple), yielding exit value $38.2M. After 20% dilution, upside is 280%.
Revenue grows to $4.78M, exit multiple settles at 6x (comp median), exit value $28.7M. Net of 20% dilution, upside 180%.
Revenue grows to $4.78M but multiple contracts to 3x (current level), exit value $14.3M. After 20% dilution, upside 30%; preference stack risk minimal.
Preference Stack Risk
lowFunding Intensity
0%No preferred stock or total funding data available; assumed minimal preference overhang.
Dilution Risk
moderateLikely need to raise capital within 2 years; assumed 20% dilution from option pool and future rounds.
Secondary Liquidity
limitedA secondary transaction occurred in Feb 2025, indicating some liquidity, but no active market.
Questions to Ask at the Interview
Strategic questions based on iLabService's data — designed to show you've done your homework.
- 1
“How does iLabService differentiate from LabWare LIMS and STARLIMS in terms of AIoT integration?”
- 2
“What is the revenue mix between SaaS subscriptions and hardware sales, and what are the associated margins?”
- 3
“What is the company's hiring plan and when is the next primary financing round expected?”
Community
Valuation Sentiment
Our model estimates +163% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.